Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinoma. [electronic resource]
- Journal of biological response modifiers Dec 1989
- 571-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
0732-6580
Aged Carcinoma, Squamous Cell--drug therapy Combined Modality Therapy Female Follow-Up Studies Head and Neck Neoplasms--drug therapy Humans Injections Interleukin-2--administration & dosage Lymph Nodes Male Middle Aged Pilot Projects